Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Coronary Artery Disease: HELP
Robert F. Riley
Based on 5 articles published since 2008
||||
Expertise Level
The expertise of Robert F. Riley ranks in the Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    University of Washington   Contact    
2018
  • From the Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, NC. · Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC. · Division of Cardiology, University of Washington, Seattle, WA. · Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC. · Pubmed 29768320
2017
  • Division of Cardiology, University of Washington, School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA. · Division of Cardiology, University of Washington, School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA. Electronic address: · Pubmed 28600093
  • Division of Cardiology, University of Washington, Seattle, WA, USA. · Division of Cardiology, University of Washington, Seattle, WA, USA. · Division of Cardiology, Swedish Medical Center, Seattle, WA, USA. · Pubmed 28315181
2011
  • Department of Medicine, University of Washington, Seattle, WA, USA. · Pubmed 21304092
2009
  • University of Washington, Department of Medicine, Seattle, WA 98104, USA. · Pubmed 19790016
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Robert F. Riley in 2008-2019 about Coronary Artery Disease:

  • Monocyte Chemoattractant Protein-1 as a Predictor of Coronary Atherosclerosis in Patients Receiving Coronary Angiography. 2018
  • Multivessel Revascularization in Shock and High-Risk Percutaneous Coronary Intervention. 2017
  • Update on the Management of Chronic Total Occlusions in Coronary Artery Disease. 2017
  • Trends in coronary revascularization in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes. 2011
  • Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease. 2009
Show List of Full Article Records
Google Searches

Learn more about Robert F. Riley using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Washington
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Washington
2018
  • From the Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, NC. · Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC. · Division of Cardiology, University of Washington, Seattle, WA. · Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC. · Pubmed 29768320
2017
  • Division of Cardiology, University of Washington, School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA. · Division of Cardiology, University of Washington, School of Medicine, 1959 Northeast Pacific Street, Seattle, WA 98195, USA. Electronic address: · Pubmed 28600093
  • Division of Cardiology, University of Washington, Seattle, WA, USA. · Division of Cardiology, University of Washington, Seattle, WA, USA. · Division of Cardiology, Swedish Medical Center, Seattle, WA, USA. · Pubmed 28315181
2011
  • Department of Medicine, University of Washington, Seattle, WA, USA. · Pubmed 21304092
2009
  • University of Washington, Department of Medicine, Seattle, WA 98104, USA. · Pubmed 19790016
Yearly article counts 012000001010
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.